13: The Outcome of Allogeneic Stem Cell Transplantation (alloSCT) for the Treatment of Therapy-Related Myelodysplastic Syndrome (tMDS) and Acute Myeloid Leukemia (tAML) Varies Considerably by Risk Factor: An Observational Study From the Center for International Blood and Marrow Transplant Research (CIBMTR)

Myeloid Leukemia ◽

Marrow Transplant ◽

Blood And Marrow Transplant ◽

Allogeneic Stem Cell Transplantation for FLT3-Mutated Acute Myeloid Leukemia: In vivo T-Cell Depletion and Posttransplant Sorafenib Maintenance Improve Survival. A Retrospective Acute Leukemia Working Party-European Society for Blood and Marrow Transplant Study

Clinical Hematology International ◽

10.2991/chi.d.190310.001 ◽

2019 ◽

Vol 1 (1) ◽

pp. 58 ◽

Cited By ~ 17

Author(s):

Ali Bazarbachi ◽

Myriam Labopin ◽

Giorgia Battipaglia ◽

Azedine Djabali ◽

Edouard Forcade ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Acute Leukemia ◽

Myeloid Leukemia ◽

Working Party ◽

Marrow Transplant ◽

Blood And Marrow Transplant ◽

Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis

Cancer ◽

10.1002/cncr.30140 ◽

2016 ◽

Vol 122 (19) ◽

pp. 3005-3014 ◽

Cited By ~ 17

Author(s):

Abhinav Deol ◽

Salyka Sengsayadeth ◽

Kwang Woo Ahn ◽

Hai-Lin Wang ◽

Mahmoud Aljurf ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Myeloid Leukemia ◽

Marrow Transplant ◽

Hematopoietic Stem ◽

Blood And Marrow Transplant ◽

Mutation Impact ◽

Charlson comorbidity index predicts outcomes of elderly after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome

Journal of the Formosan Medical Association ◽

10.1016/j.jfma.2020.12.021 ◽

2021 ◽

Author(s):

Sheng-Hsuan Chien ◽

Ming Yao ◽

Chi-Cheng Li ◽

Ping-Ying Chang ◽

Ming-Sun Yu ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Charlson Comorbidity Index ◽

Myeloid Leukemia ◽

Hematopoietic Stem ◽

Comorbidity Index ◽

Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome

Bone Marrow Transplantation ◽

10.1038/sj.bmt.1705603 ◽

2007 ◽

Vol 39 (8) ◽

pp. 509-509 ◽

Cited By ~ 1

Author(s):

H Sill ◽

W Zinke-Cerwenka ◽

A Berghold

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Myeloid Leukemia ◽

Azacitidine as salvage therapy for relapsed acute myeloid leukemia/myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation

Advances in Cell and Gene Therapy ◽

10.1002/acg2.58 ◽

2019 ◽

Vol 2 (3) ◽

Cited By ~ 1

Author(s):

Takayuki Ozawa ◽

Shigeo Fuji ◽

Ichiro Kawashima ◽

Yuki Sueki ◽

Masao Hagihara ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Salvage Therapy ◽

Myeloid Leukemia ◽

Hematopoietic Stem ◽

Relapsed Acute Myeloid Leukemia ◽

Busulfan Dose Intensity and Outcomes in Reduced-Intensity Allogeneic Peripheral Blood Stem Cell Transplantation for Myelodysplastic Syndrome or Acute Myeloid Leukemia

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2013.03.016 ◽

2013 ◽

Vol 19 (6) ◽

pp. 981-987 ◽

Cited By ~ 30

Author(s):

Yi-Bin Chen ◽

Erin Coughlin ◽

Kevin F. Kennedy ◽

Edwin P. Alyea ◽

Philippe Armand ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Myeloid Leukemia ◽

Peripheral Blood Stem Cell ◽

Dose Intensity ◽

Blood Stem Cell Transplantation ◽

Reduced Intensity ◽

T-Cell Receptor Excision Circle Levels After Allogeneic Stem Cell Transplantation Are Predictive of Relapse in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome

Stem Cells and Development ◽

10.1089/scd.2013.0588 ◽

2014 ◽

Vol 23 (14) ◽

pp. 1559-1567 ◽

Cited By ~ 6

Author(s):

Mehmet Uzunel ◽

Darius Sairafi ◽

Mats Remberger ◽

Jonas Mattsson ◽

Michael Uhlin

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

T Cell ◽

T Cell Receptor ◽

Allogeneic Stem Cell Transplantation ◽

Myeloid Leukemia ◽

Cell Receptor ◽

Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS)

Bone Marrow Transplantation ◽

10.1038/sj.bmt.1705259 ◽

2006 ◽

Vol 37 (4) ◽

pp. 339-344 ◽

Cited By ~ 65

Author(s):

N Kröger ◽

A Shimoni ◽

T Zabelina ◽

H Schieder ◽

J Panse ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Elderly Patients ◽

Myeloid Leukemia ◽

Secondary Acute Myeloid Leukemia ◽

Preparative Regimen ◽

Reduced Toxicity ◽

Nonmyeloablative Stem Cell Transplantation for Myelodysplastic Syndrome or Acute Myeloid Leukemia in Patients 60 Years or Older

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2005.06.006 ◽

2005 ◽

Vol 11 (10) ◽

pp. 764-772 ◽

Cited By ~ 52

Author(s):

Vikas Gupta ◽

Andrew Daly ◽

Jeffrey H. Lipton ◽

Wanda Hasegawa ◽

Kathy Chun ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Cell Transplantation ◽

Myeloid Leukemia ◽

Nonmyeloablative Stem Cell Transplantation ◽

Evaluation of reduced intensity allogeneic hematopoietic stem cell transplantation (HSCT) using anti lymphocyte antibodies in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.6544 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 6544-6544

Author(s):

U. R. Popat ◽

G. Carrum ◽

R. Krance ◽

M. Brenner ◽

H. Heslop

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Cell Transplantation ◽

Myeloid Leukemia ◽

Hematopoietic Stem ◽

Reduced Intensity ◽